Ying Jiang

7.2k total citations
229 papers, 4.9k citations indexed

About

Ying Jiang is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Ying Jiang has authored 229 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Epidemiology, 74 papers in Infectious Diseases and 50 papers in Oncology. Recurrent topics in Ying Jiang's work include Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (39 papers) and Central Venous Catheters and Hemodialysis (33 papers). Ying Jiang is often cited by papers focused on Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (39 papers) and Central Venous Catheters and Hemodialysis (33 papers). Ying Jiang collaborates with scholars based in United States, China and Ireland. Ying Jiang's co-authors include Issam Raad, Ray Hachem, Dimitrios P. Kontoyiannis, Roy F. Chemaly, Ruth Reitzel, Hend Hanna, Anne‐Marie Chaftari, Tanya Dvorak, Harrys A. Torres and Russell E. Lewis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ying Jiang

219 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ying Jiang United States	40	2.3k	2.0k	775	598	533	229	4.9k
Sílvia Figueiredo Costa Brazil	41	2.2k 1.0×	1.9k 1.0×	446 0.6×	877 1.5×	253 0.5×	221	5.8k
Maria J. G. T. Vehreschild Germany	35	2.0k 0.9×	3.7k 1.9×	649 0.8×	797 1.3×	116 0.2×	161	5.4k
Jun‐ichi Kadota Japan	43	2.2k 1.0×	1.0k 0.5×	570 0.7×	774 1.3×	238 0.4×	369	6.5k
Burke A. Cunha United States	37	2.1k 0.9×	1.5k 0.7×	291 0.4×	803 1.3×	164 0.3×	361	6.0k
Deborah Thompson United States	24	1.5k 0.6×	1.8k 0.9×	237 0.3×	1.4k 2.3×	408 0.8×	72	5.7k
W. Michael Scheld United States	40	3.8k 1.7×	1.6k 0.8×	276 0.4×	899 1.5×	119 0.2×	102	8.6k
Elizabeth Molyneux Malawi	47	1.7k 0.8×	1.2k 0.6×	988 1.3×	722 1.2×	120 0.2×	226	6.9k
Pierre Tattevin France	45	3.9k 1.7×	4.0k 2.0×	386 0.5×	937 1.6×	91 0.2×	331	8.2k
Rob Roy MacGregor United States	46	2.4k 1.0×	1.9k 1.0×	513 0.7×	1.0k 1.7×	89 0.2×	128	6.9k
Jan Fehr Switzerland	38	1.4k 0.6×	2.0k 1.0×	295 0.4×	538 0.9×	288 0.5×	195	5.7k

Countries citing papers authored by Ying Jiang

Since Specialization

Citations

This map shows the geographic impact of Ying Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Jiang more than expected).

Fields of papers citing papers by Ying Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Jiang. The network helps show where Ying Jiang may publish in the future.

Co-authorship network of co-authors of Ying Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Jiang. A scholar is included among the top collaborators of Ying Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Jiang. Ying Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Ying, et al.. (2025). Multi-omics analysis reveals mechanisms of FMT in Enhancing antidepressant effects of SSRIs. Brain Behavior and Immunity. 126. 176–188. 2 indexed citations

George, Mónica, Sairah Ahmed, Sheeba K. Thomas, et al.. (2025). Direct‐Acting Antivirals Induce Lymphoproliferative Disease Response in HCV‐Infected Patients With Indolent B‐Cell Non‐Hodgkin’s Lymphoma: A Prospective Observational Study. Hematological Oncology. 43(2). e70044–e70044. 1 indexed citations

Shafat, Tali, Fareed Khawaja, Ying Jiang, et al.. (2025). Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma: A 7-Year Retrospective Cohort Study. Open Forum Infectious Diseases. 12(4). ofaf127–ofaf127.

Li, Rende, et al.. (2025). Core capability boundaries in library Reading promotion: Insourcing versus outsourcing configurations. IFLA Journal.

Matsuo, Takahiro, Sebastian Wurster, Ying Jiang, et al.. (2024). The modern face of esophageal candidiasis in an oncology center: Correlating clinical manifestations, endoscopic grade, and pathological data in 323 contemporary cancer patients. Journal of Infection. 89(1). 106172–106172. 1 indexed citations

Matsuo, Takahiro, Sebastian Wurster, Ying Jiang, Jeffrey J. Tarrand, & Dimitrios P. Kontoyiannis. (2024). Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordance Between Responses of Skin Lesions and Systemic Outcomes. Open Forum Infectious Diseases. 11(2). ofae068–ofae068. 1 indexed citations

Jiang, Ying, et al.. (2024). CEO industry tournament, investor attention, and company value. Managerial and Decision Economics. 45(6). 4084–4104. 4 indexed citations

Rosenblatt, Joel, Ying Jiang, Samuel A. Shelburne, et al.. (2024). In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC-Antimicrobial Resistance. 6(2). dlae060–dlae060. 6 indexed citations

Khawaja, Fareed, Sairah Ahmed, Swaminathan P. Iyer, et al.. (2024). Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes. Open Forum Infectious Diseases. 11(8). 63–64. 11 indexed citations

10.

Jiang, Ying, et al.. (2023). Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients. SHILAP Revista de lepidopterología. 50(9).

11.

Hachem, Ray, et al.. (2023). 528. Matched Retrospective Study, Comparing Molnupiravir to Nirmatrelvir-Ritonavir (Paxlovid) in the Treatment of Mild-Moderate COVID-19 in Immunocompromised Cancer Patients. Open Forum Infectious Diseases. 10(Supplement_2).

12.

Matsuo, Takahiro, Sebastian Wurster, Ying Jiang, et al.. (2023). Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. Journal of Antimicrobial Chemotherapy. 79(2). 297–306. 8 indexed citations

13.

Chowdhary, Anuradha, Nitesh Gupta, Sebastian Wurster, et al.. (2023). Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors. Mycoses. 66(6). 515–526. 9 indexed citations

14.

Khawaja, Fareed, Adina L. Feldman, Vinod Ravi, et al.. (2023). COVID‐19 in cancer patients: The impact of vaccination on outcomes early in the pandemic. Cancer Medicine. 12(24). 22006–22022. 5 indexed citations

15.

Chaftari, Anne‐Marie, Ray Hachem, Alexandre Malek, et al.. (2022). A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open Forum Infectious Diseases. 9(6). ofac079–ofac079. 9 indexed citations

16.

Chaftari, Anne‐Marie, et al.. (2021). Management of enterococcal central line-associated bloodstream infections in patients with cancer. BMC Infectious Diseases. 21(1). 12 indexed citations

17.

Economides, Minas P., Moran Amit, Parag Mahale, et al.. (2017). Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer. Cancer. 124(5). 960–965. 6 indexed citations

18.

Gomes, Marisa Zenaide Ribeiro, Victor E. Mulanovich, Ying Jiang, Russell E. Lewis, & Dimitrios P. Kontoyiannis. (2013). Incidence Density of Invasive Fungal Infections during Primary Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Patients in a Tertiary Cancer Center, 2009 to 2011. Antimicrobial Agents and Chemotherapy. 58(2). 865–873. 41 indexed citations

19.

Ramos, Elizabeth, Ying Jiang, Ray Hachem, et al.. (2011). Outcome Analysis of Invasive Aspergillosis in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients: The Role of Novel Antimold Azoles. The Oncologist. 16(7). 1049–1060. 43 indexed citations

20.

Hachem, Ray, Ruth Reitzel, Agatha Borne, et al.. (2009). Novel Antiseptic Urinary Catheters for Prevention of Urinary Tract Infections: Correlation of In Vivo and In Vitro Test Results. Antimicrobial Agents and Chemotherapy. 53(12). 5145–5149. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact